99% Purity Muscle Building SARMs Raw Powder Lgd3303 / Lgd-3303 for Bodybuilding 1196133-39-7
- Hersteller: Dewael
- Produkttest: 99%+
- Aussehen:weißes kristallines Pulver.
- Herkunftsort: China
- Zertifizierung: SGS,ISO9001, GMP
- Mindestbestellmenge: 10G
- Verpackungsinformationen: Diskreter Möglichkeiten der Verpackung für den Zoll garantiert
- Lieferzeit: Innerhalb 12 Stunden nach Eingang Ihrer Zahlung
- Zahlungsbedingungen: Western Union, Moneygram,Bitcoin,Banküberweisung
- Versand: EMS,DHL,Fedex,UPS,TNT und so weiter.
- Politik: Re-Schifffahrtspolitik
- Lieferfähigkeit: 500-600kg/Monat
99% Purity Muscle Building SARMs Raw Powder Lgd3303 / Lgd-3303 for Bodybuilding 1196133-39-7
Produktname: 9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one
Synonyme: 9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one;LGD-3303
CAS: 1196133-39-7
MF: C16H14ClF3N2O
MW: 342.7433696
Reinheit:97%
Aussehen:weißes Pulver
LGD-3303 like LG121071, was developed by Ligand Pharmaceuticals. The chemical structure of LGD-3303 resembles that of LGD-4033, another SARM developed by Ligand Pharmaceuticals.LGD 3303 is NOT Anamorelin. It is the most potent SARM we have seen personally to date!
More details about LGD3033 SARMs powder :
LGD 3303 – Most Anabolic SARMs powder?
LGD 3303 – Most Anabolic SARMs powder? This video is about LGD 3303. There has been a lot of confusion about LGD 3303 being the growth hormone secretagogue Anamorelin and also being called LGD 3033 instead of LGD 3303. After doing our own research, and learning from our personal experiences, we decided to make this video going into detail the best we can about LGD 3303. LGD 3303 is NOT Anamorelin. It is the most potent SARM we have seen personally to date! We are excited to see what happens as more information becomes available but from our experiences we are very impressed with the muscle building potential.
We borrowed the figures below from a 2009 publication, which shows the effect of orally administered LGD-3303 in rats. The solid black line represents the size of the prostate, the size of the levator ani and the concentration of LH in intact animals. The vertical bars represent the same values in castrated animals. In terms of muscle mass, a dose of 1 mg per kg per day of LGD-3303 was sufficient to completely replace the natural testosterone production. The human equivalent of this dose, for a man weighing 80 kg, would be about 11 mg pro Tag. Animal studies have shown that a combination of LGD-3303 and bisphosphonate protects bone mass.
What is LGD-3303?
LGD-3303 is a drug which acts as a selective androgen receptor modulator (SARM), with good oral bioavailability. It is a selective agonist for the androgen receptor, producing functional selectivity with effective dissociation of anabolic and androgenic effects, acting as a partial agonist for androgenic effects, but a full agonist for anabolic effects. It has been investigated as a possible treatment for osteoporosis, and was shown in animal studies to enhance the effectiveness of a bisphosphonate drug.
LGD-3303 Benefits
1) Shows potential to increase muscle mass
2) Minimal Side Effects
3) Doesn’t negatively impact androgenic organs
4) Significantly increased muscle activity
5) Prevents muscle wasting
6) Works well as a stand alone or stacked with other SARMS
7) Great results in every aspect for different types of goals
LGD-3303 Dosage Recommand:
LGD-3303: 20mg split dose every 8-9 Std. (may increase as time goes on).
SR-9009: 20mg split does, 7mg pre workout, 7mg 3 hours later, 6mg 3 hours after second dose (may increase to 30mg if necessary).
Andere Verwandte SARMs:
Name | CAS-NR. | Verwendung |
AICAR | 2627-69-2 | wirkt durch die Nukleosid-Pools Eingabe, deutlich Adenosinspiegel während der Perioden des ATP Abbaus zu erhöhen |
Nk2866 | 841205-47-8 | ärztliche Verschreibung zur Verhinderung von Kachexie, Atrophie, und Sarkopenie und für Hormone oder Testoserone Ersatztherapie. |
MK-677 | 15972-10-0 | Ein Wachstumshormon-Sekretagogum, Behandlung von Fettleibigkeit, eine vielversprechende Therapie für die Behandlung von Gebrechlichkeit bei älteren Menschen |
LGD-4033 | 1165910-22-4 | pharmakologisches Profil ähnlich dem von enobosarm, ostarine,MK-2866 |
GW501516 | 317318-70-0 | für Fettleibigkeit, Diabetes, Dyslipidämie und Herz-Kreislauf- Erkrankungen |
Andarine(S4) | 401900-40-0 | partielle Agonisten, vor allem für die Behandlung der benignen Prostatahyperplasie vorgesehen |
SR9009 | 1379686-30-2 | in der Entwicklung am Scripps Research Institute (TSRI), erhöht den Grad der metabolischen Aktivität in Skelettmuskeln von Mäusen |
RAD140 | 1182367-47-0 | Neue Generation für Masseaufbau und Schneiden |
YK11 | 431579-34-9 | YK11: ein SARM und Myostatin-Inhibitor auf in |
———————————————————————————————————————————————————————————————————————————————————————-
Kontaktieren Sie mich jetzt
Bewertungen
Es gibt noch keine Kommentare.